We kindly inform you that, as long as the subject affiliation of our 300.000+ articles is in progress, you might get unsufficient or no results on your third level or second level search. In this case, please broaden your search criteria.
The following sketch aims at presenting the academic achievements of one of the chief Polish professors of the Roman Law, Edward Szymoszek, chair of the Department of the Roman Law at the Faculty of Law and Administration at the University of Silesia, and a chair of the Department of the Roman Law at the Institute of the History of the State and the Law at the Faculty of Law and Administration at the University of Wrocław. This publication is even more justified considering the fact that currently there are no monographs which would constitute a bibliography of the professor. Therefore, the presented sketch could be useful in research on the state of the Roman law in the Middle Ages, a subject on which professor Szymoszek published extensively.
More...
INTRODUCTION: PATIENTS WITH A HISTORY OF NEOPLASIA REPRESENT A SPECIAL CATEGORY. THEYREQUIRE LONG AND MULTIDISCIPLINARY FOLLOW-UP BECAUSE OF THE RISK OF SECONDARYDETERMINATIONS, ESPECIALLY IN THE LUNG, WHICH IS A FILTER IN THE PATH OF HEMATOGENOUSDISSEMINATION. METASTASES APPEAR AS SOLITARY OR MULTIPLE PULMONARY NODULES. THEEXISTENCE OF A SOLITARY PULMONARY NODULE MAY REPRESENT A SYNCHRONOUS ORMETACHRONOUS PULMONARY LESION, NOT A SECONDARY DETERMINATION.MATERIAL AND METHODS: THE AUTHORS PRESENT A RETROSPECTIVE DESCRIPTIVE STUDYREGARDING PATIENTS WITH A HISTORY OF NEOPLASIA, THAT WERE HOSPITALIZED IN THE THORACICSURGERY CLINIC IN 2014 FOR PULMONARY NODULES. INCLUDED IN THIS STUDY WERE PATIENTS WHOUNDERWENT CURATIVE TREATMENT FOR UROGENITAL OR DIGESTIVE TRACT NEOPLASIA.RESULTS: FORTY-FOUR PATIENTS WITH PREVIOUS UROGENITAL CANCERS OR TUMORS OF THEDIGESTIVE TRACT UNDERWENT SURGICAL TREATMENT. THE HISTOLOGIC RESULTS CONFIRMEDMETASTASES IN 30 CASES (68%), PRIMARY LUNG CANCER IN 11 (25%) AND BENIGN PULMONARY LESIONSIN 3 (7%).DISCUSSIONS: THE APPEARANCE OF A PULMONARY NODULE IN PATIENTS WITH A HISTORY OFNEOPLASIA IS SUSPICIOUS FOR METASTATIC DISEASE, BUT A PRIMARY CANCER CAN'T BE EXCLUDED.DIAGNOSIS AND EFFECTIVE TREATMENT REQUIRES AN INTERDISCIPLINARY COLLABORATIONBETWEEN RADIOLOGIST, ONCOLOGIST, PULMONOLOGIST, THORACIC SURGEON AND PATHOLOGIST.CONCLUSIONS: SOLITARY PULMONARY NODULES, IN A PATIENT WITH A PREVIOUS HISTORY OFNEOPLASIA, SHOULD RECEIVE HISTOPATHOLOGICAL CONFIRMATION FOR THE APPROPRIATETHERAPEUTIC APPROACH.
More...
TO ESTABLISH THE RISK OF TUMORAL RECURRENCE FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) DEPENDINGON HISTOLOGICAL OR ENVIRONMENTAL FACTORS. THE AIM OF THIS PAPER IS TO IMPROVE THE STANDARD CLINICAL CARE IN NMIBC PATIENTS FOLLOW-UP.WE INITIALLY EVALUATED 987 PATIENTS DIAGNOSED WITH BLADDER CANCER BETWEEN JANUARY 2005 AND DECEMBER 2014. MUSCLE-INVASIVE BLADDER CANCER (MIBC) WAS DIAGNOSED FOR 309 PATIENTS (31.3%) WHILE 678 (68.7%) HAD NMBIC. A TOTAL OF 540 PATIENTS WITH NMIBC WERE ANALYZED IN THE STUDY, WHILETHE OTHER 138 (20.4%) WERE EXCLUDED DUE TO INCOMPLETE CLINICAL DATA OR FOLLOW-UP. THE RETROSPECTIVE STUDYANALYZED PATIENTS’ CHARTS, DISCHARGE NOTES, ONCOLOGY REPORTS. PATIENTS WITH AT LEAST 3 YEARS COMPLETEFOLLOW-UP DATA WERE ENROLLED.THE AVERAGE AGE OF DIAGNOSED PATIENTS WITH NMIBC WAS 65.3 YEARS. THEMAJORITY OF PATIENTS WERE DIAGNOSED WITH SINGLE TUMORS (68.5%). NMIBC WAS PREDOMINANT IN MALES, WITH A SEXRATIO 3.25:1 FOR MALES. BLADDER TRIGON IS THE MAIN LOCATION FOR BLADDER TUMORS. SMOKING WAS THE MAIN RISKFACTOR ACCORDING TO OUR RESULTS. SMOKERS HAD A 4 TIMES HIGHER RISK FOR NMIBC DEVELOPMENT. PATIENTS WITHMULTIPLE BLADDER TUMORS HAD 2.28 HIGHER RISK OF RECURRENCE. OVERALL RECURRENCE FOR NMIBC WAS 49.1%.SMOKING IS THE MOST IMPORTANT RISK FACTOR AND THE RECURRENCE RATE IS HIGHER IN SMOKING-PATIENTS.ALSO,PATIENTS WITH MULTIPLE TUMOURS HAVE BEEN DIAGNOSED WITH HIGHER RISK FOR TUMOR RECURRENCE (P<0.05). LARGETUMORS AND PATIENTS WITH ASSOCIATED UROLOGICAL CONDITIONS HAVE HIGHER RISK OF TUMORAL RECURRENCE (OR =2.2).
More...
HEPATITIS C VIRUS (HCV) IS A MAJOR CAUSE OF CHRONIC LIVER DISEASE WORLDWIDE. AN INCREASED PREVALENCE OF STEATOSIS IN PATIENTS WITH HCV IS WELL ESTABLISHED. MOSTSTUDIES HAVE REPORTED APPROXIMATELY 50% PREVALENCE OF STEATOSIS AMONG PATIENTSUNDERGOING A LIVER BIOPSY BECAUSE OF HCV. IN COMPARISON, AMONG PATIENTS WITH AUTOIMMUNE HEPATITIS AND HEPATITIS B (HBV), STEATOSIS IS NOT COMMONLY OBSERVED. HEPATITIS C VIRUS (HCV) INFECTION IS AN IMPORTANT RISK FACTOR FOR INSULIN RESISTANCE(IR). THE LATTER IS THE PATHOGENIC FOUNDATION UNDERLYING METABOLIC SYNDROME,STEATOSIS AND CIRRHOSIS, AND POSSIBLY HEPATOCELLULAR CARCINOMA (HCC). WHEREAS THEOVERALL PREVALENCE OF IR IS 10%-25% OF THE POPULATION, THE PREVALENCE IR IN HCVINFECTION REACHES FIGURES RANGING BETWEEN 30% TO 70%. OBESITY AND/OR STEATOSIS INPATIENTS WITH CHRONIC HCV HAS CONSISTENTLY BEEN SHOWN TO BE ASSOCIATED WITH ANIMPAIRED RESPONSE TO ANTIVIRAL TREATMENT WITH INTERFERON THERAPY. IT IS NOT CLEARWHETHER THIS ASSOCIATION BETWEEN OVERWEIGHT OR OBESITY AND POOR RESPONSE TOANTIVIRAL THERAPY IS DUE TO STEATOSIS AND MIGHT NOT ONLY BE LINKED TO OBESITY.ACCUMULATING EVIDENCE SUGGESTS THAT STEATOSIS PLAYS A ROLE IN HCV-RELATEDFIBROSIS, AND SUPPORT FOR THIS ALSO COMES FROM STUDIES SHOWING THAT WEIGHTREDUCTION IN THESE PATIENTS LEADS NOT ONLY TO A DECREASE IN STEATOSIS BUT ALSOIMPROVEMENT IN FIBROSIS SCORE.
More...
THIS PAPER PRESENTS THE DEVELOPMENT, IMPLEMENTATION AND TESTING OF AN AIR QUALITYMONITORING SYSTEM. THE SYSTEM IS BASED ON THE ARCHITECTURE OF A METROPOLITAN WSNSENSOR NETWORK OF THE LARGE SCALE TYPE, SPREAD ON A WIDE GEOGRAPHICAL AREA ANDTHUS COMPLYING WITH THE SMART CITY CONCEPT. THUS, THE LOCAL AUTHORITIES CAN MAKEDECISIONS CONCERNING THE REDUCTION OF THE POLLUTION LEVEL IN TERMS OF THE QUANTITYOF PM10 PARTICLES IN THE AIR. THE ARCHITECTURE IS OF THE CLIENT SERVER TYPE, USING THEJENNET COMMUNICATION PROTOCOL AND THE SYSTEM CAN INTEGRATE A LARGE NUMBER OFNODES. THE OBTAINED RESULTS SHOW THAT THE SYSTEM HAS A HIGH EFFICIENCY LEVEL ANDCAN BE INTEGRATED IN THE SMART CITY CONCEPT.
More...
STUDIES ON OPERATIONAL RELIABILITY AND DURABILITY OF MACHINES BECAME AN IMPORTANTISSUE BECAUSE OF EXIGENCIES IN TERMS OF MAINTAINING ACCURACY WHILE PROCESSING RAPIDREPLACEMENT OF WORN MACHINE TOOLS BY NEW ONES. MACHINE TOOLS ARE USED AT THEOPERATING REGIMES MORE INTENSE, WITH AN INCREASING DEGREE OF USE AND REQUIREMENTSFOR WEIGHT REDUCTION AND GAUGE WITH A GREAT EMPHASIS ON PRECISION PROCESSINGDURING OPERATION. THIS PAPER DESCRIBES THE STUDY ABOUT INDICATORS OF RELIABILITY OFMILLING MACHINES USING MONTE CARLO SIMULATION BASED ON TIME OF FAILURE.
More...
PURPOSE. TO REPORT A CASE OF A YOUNG WOMAN WITH RECURENT EPISODES OF HEAVY VAGINALBLEEDING THAT ALTERNATED WITH PERIODS OF MODERATE BLEEDING. THE PATIENT HAS BEENDIAGNOSED WITH UTERINE ARTERIOVENOUS MALFORMATION IN THE RADIOLOGY DEPARTMENTOF THE UNIVERSITY EMERGENCY HOSPITAL BUCHAREST. GONADOTROPIN-RELEASING HORMONEAGONISTS HAVE BEEN USED AS AN ADJUNCT TO EMBOLIZATION. SUBSEQUENT UTERINE VEINSEMBOLIZATION RESULTED IN COMPLETE DISAPPEARANCE OF THE ARTERIO-VENOUSMALFORMATION, AND NORMAL CYCLES WERE RESUMED TWO MONTHS LATER.DESIGN. CASE REPORTPATIENT. 28 YEARS OLD WOMAN WITH RECURRENT METRORRHAGIASEXPECTED OUTCOME. DISAPPEARANCE OF AN INTRAUTERINE ARTERIOVENOUS MALFORMATIONTREATMENT. GONADOTROPIN-RELEASING HORMONE AGONISTS AND UTERINE VEINSEMBOLIZATION DIAGNOSIS. UTERINE ARTERIOVENOUS MALFORMATIONCONCLUSION. SUBSEQUENT UTERINE VEINS EMBOLIZATION RESULTED IN COMPLETEDISAPPEARANCE OF THE ARTERIO-VENOUS MALFORMATION, AND NORMAL CYCLES WERERESUMED TWO MONTHS LATER.
More...